Last updated: March 24, 2022
Sponsor: Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health
Overall Status: Active - Recruiting
Phase
N/A
Condition
Stroke
Cerebral Ischemia
Treatment
N/AClinical Study ID
NCT05309148
Eye001
Ages 30-80 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- signed consent
- at least 3 points on the Rankin scale;
- the presence of disorders of the visual-oculomotor system, visual attention;
- understanding and following instructions; stable vegetative and hemodynamicparameters;
- on the MOOCA scale >22;
- patients should be fully examined for the underlying and concomitant disease (examination by a neurologist, ophthalmologist, physiotherapist);
Exclusion
Exclusion Criteria:
- 4, 5 points on the Rankin scale;
- unstable hemodynamics;
- time after stroke is less than 2 weeks;
- presence of epileptic activity;
- serious ophthalmological disorders (for example, partial atrophy of the optic nerve);
Study Design
Total Participants: 50
Study Start date:
January 10, 2022
Estimated Completion Date:
December 20, 2024
Study Description
Connect with a study center
Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency
Moscow, 117513
Russian FederationActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.